Browse Studies — Arctuva

Phase 2

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Clazakizumab in Reducing hsCRP in Adults With Elevated hsCRP and Established ASCVD or at Increased Risk for ASCVD Events

The purpose of this study is to measure the change in high-sensitivity C-reactive protein (hsCRP), a marker of inflammation in the body, with clazakizumab comp…

AtherosclerosisCardiovascular DiseaseObesity+3 more

Estimated

~$10 – $7,500

Eli Lilly and CompanyNCT07783802

Phase 3

A Phase III, Randomised, Double-blind, Study to Evaluate the Effect of Balcinrenone/Dapagliflozin Compared With Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Chronic Kidney Disease (Stage 3b and 4)

The purpose of this study is to evaluate the efficacy, safety and tolerability of balcinrenone in fixed combination with dapagliflozin, compared with dapaglifl…

Renal Insufficiency, Chronic

Estimated

~$10 – $7,500

AstraZenecaNCT07624305

Phase 2

Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease

The purpose of this study is to find out why patients with chronic kidney disease (CKD) have poor exercise capacity and to explore what causes an increase in b…

Renal Insufficiency, Chronic

Estimated

~$10 – $6,250

Emory UniversityNCT02947750

Transformative Research in Diabetic Nephropathy 2.0: A Proof of Principle Study of SGLT2 Inhibitors (TRIDENT 2.0)

The goal of this observational study is to learn more about kidney health in adults with diabetic kidney disease and other groups. Researchers will study kidne…

Diabetic NephropathiesKidney DiseasesRenal Insufficiency, Chronic+1 more

Estimated

~$10 – $750

University of PennsylvaniaNCT07444203